380 related articles for article (PubMed ID: 28770597)
1. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
2. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
3. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
[TBL] [Abstract][Full Text] [Related]
4. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
5. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
[TBL] [Abstract][Full Text] [Related]
6. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
Hagey JM; Li X; Barr-Walker J; Penner J; Kadima J; Oyaro P; Cohen CR
AIDS Care; 2018 Dec; 30(12):1477-1487. PubMed ID: 30037312
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
[TBL] [Abstract][Full Text] [Related]
8. Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach.
Zakumumpa H; Bennett S; Ssengooba F
BMC Health Serv Res; 2017 Jan; 17(1):65. PubMed ID: 28114932
[TBL] [Abstract][Full Text] [Related]
9. Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals.
Prust ML; Banda CK; Nyirenda R; Chimbwandira F; Kalua T; Jahn A; Eliya M; Callahan K; Ehrenkranz P; Prescott MR; McCarthy EA; Tagar E; Gunda A
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21650. PubMed ID: 28770594
[TBL] [Abstract][Full Text] [Related]
10. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries.
Cerecero-García D; Pineda-Antunez C; Alexander L; Cameron D; Martinez-Silva G; Obure CD; Marseille E; Vu L; Kahn JG; Vassall A; Gomez G; Bollinger L; Levin C; Bautista-Arredondo S
Afr J AIDS Res; 2019 Dec; 18(4):297-305. PubMed ID: 31779577
[No Abstract] [Full Text] [Related]
12. The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa.
Fatti G; Jackson D; Goga AE; Shaikh N; Eley B; Nachega JB; Grimwood A
J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485714
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.
Fatti G; Ngorima-Mabhena N; Chirowa F; Chirwa B; Takarinda K; Tafuma TA; Mahachi N; Chikodzore R; Nyadundu S; Ajayi CA; Mutasa-Apollo T; Mugurungi O; Mothibi E; Hoffman RM; Grimwood A
Trials; 2018 Jan; 19(1):79. PubMed ID: 29378662
[TBL] [Abstract][Full Text] [Related]
14. Community-supported models of care for people on HIV treatment in sub-Saharan Africa.
Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N
Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries.
Bianchi F; Cohn J; Sacks E; Bailey R; Lemaire JF; Machekano R;
Lancet HIV; 2019 Jun; 6(6):e373-e381. PubMed ID: 30987937
[TBL] [Abstract][Full Text] [Related]
16. Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.
Galárraga O; Wirtz VJ; Figueroa-Lara A; Santa-Ana-Tellez Y; Coulibaly I; Viisainen K; Medina-Lara A; Korenromp EL
Pharmacoeconomics; 2011 Jul; 29(7):579-99. PubMed ID: 21671687
[TBL] [Abstract][Full Text] [Related]
17. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
18. Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review.
Roberts DA; Tan N; Limaye N; Irungu E; Barnabas RV
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3(Suppl 3):S339-S347. PubMed ID: 31764272
[TBL] [Abstract][Full Text] [Related]
19. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.
Atun R; Chang AY; Ogbuoji O; Silva S; Resch S; Hontelez J; Bärnighausen T
BMJ Open; 2016 Mar; 6(3):e009656. PubMed ID: 26948960
[TBL] [Abstract][Full Text] [Related]
20. Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia.
Bautista-Arredondo S; Sosa-Rubi SG; Opuni M; Contreras-Loya D; La Hera-Fuentes G; Kwan A; Chaumont C; Chompolola A; Condo J; Dzekedzeke K; Galarraga O; Martinson N; Masiye F; Nsanzimana S; Wamai R; Wang'ombe J;
PLoS One; 2018; 13(9):e0203121. PubMed ID: 30212497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
